Minneapolis Clinical Trials
Nucleus Network Minneapolis is conveniently located in the heart of the Minneapolis-St. Paul metropolitan area. We conduct FDA-approved clinical trials on behalf of drug and device manufacturers, academic and private physicians as well as other researchers across Minnesota.
We have been performing clinical studies since 2005, with the cooperative effort of our highly experienced staff, volunteers, and our pharmaceutical & academic partners. It takes the coordination of many people and organizations to safely and successfully navigate the clinical trial process and Nucleus Network is at the center of those efforts.
We are actively recruiting for new paid clinical trials, with new studies opening up all the time. Not all studies are listed on our website, so please call us at (612) 315 6490 to find out more about current and upcoming studies or register your interest here.
We perform mostly Phase 1 clinical trials, with a focus on healthy volunteer trials (participants with no medical conditions) and liver & kidney trials (participants with liver & kidney impairments). The primary purpose of a Phase 1 study is to evaluate the safety of a new drug candidate before it proceeds to further clinical studies.
No matter your health status, you can register your interest and we will be in touch if there is a clinical trial that you might be able to participate in.
Due to COVID-19 restrictions, we currently only allow participants who live within 300 miles of our clinic.
We look forward to welcoming you at our clinic soon!
- Study name
- Eligibility
- Status
- Overnight stays
- Outpatient visits
- Study name Receptor StudyEligibility
- Participants: Male participants, and/or female participants of non-childbearing potential
- Age: 18 +
- BMI 16-32kg/m2
- Medications: Not on any prescription, non-prescription, dietary, vitamins, and/or herbal supplements (birth control is allowed) for at least 7 days before the first dose
- Smoking Status: You should not have smoked tobacco or used nicotine containing products for 24 hours prior to dosing
- Study Duration: 3 inpatient stays of 8 nights and 9 days separated by 14 days
- Compensation Up to $12,529
Status Currently RecruitingOvernight stays 3 stays each 8 nightsOutpatient visits 1 visits
- Study name Celiac Disease StudyEligibility
- Participants: Biopsy and serology confirmed celiac disease
- Age: 18-70
- BMI: 18-40 kg/m2
- Medication: Medications approved on case by case basis
- Compensation: Up to $5,050
- Dose Administration: IV Infusion
Status Currently RecruitingOvernight stays 0 nightsOutpatient visits 9 visits
- Study name Cure StudyEligibility
- Age: 18-55
- BMI: 18-32kg/m2
- Medications: No current OTV or prescribed medications (other than birth control)
- Smoking Status: Non-smoker or must be able to stop smoking during the study
- Contraception: Must be willing to follow contraception guidelines from at least 14 days prior to the first dose through 60 days after the last dose.
- Compensation: Up to $7,170
Status Currently RecruitingOvernight stays 13 nightsOutpatient visits 1 visits
While you are in the clinic we provide:
If you are looking for a paid clinical trial near you, Nucleus Network Minneapolis is the place to be. We are conveniently located near the center of the Twin Cities - you can find directions to our clinic here.
You can find more information about our hepatic clinical trials here. For these studies we require participants with mild to severe liver failure.
We also have renal clinical trials, for which we require participants with mild to severe kidney failure.